These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23778909)

  • 1. Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?
    Resnick D; Bozic KJ
    Ann Intern Med; 2013 Jun; 158(12):912-3. PubMed ID: 23778909
    [No Abstract]   [Full Text] [Related]  

  • 2. Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.
    Laine C; Guallar E; Mulrow C; Taichman DB; Cornell JE; Cotton D; Griswold ME; Localio AR; Meibohm AR; Stack CB; Williams SV; Goodman SN
    Ann Intern Med; 2013 Jun; 158(12):916-8. PubMed ID: 23778911
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency.
    Kuntz RE
    Ann Intern Med; 2013 Jun; 158(12):914-5. PubMed ID: 23778910
    [No Abstract]   [Full Text] [Related]  

  • 4. A historic moment for open science: the Yale University Open Data Access project and medtronic.
    Krumholz HM; Ross JS; Gross CP; Emanuel EJ; Hodshon B; Ritchie JD; Low JB; Lehman R
    Ann Intern Med; 2013 Jun; 158(12):910-1. PubMed ID: 23778908
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
    Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
    Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YODA and truth seeking in medicine.
    Doshi P; Vedula SS; Li T
    BMJ; 2013 Jul; 347():f4251. PubMed ID: 23819966
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Recombinant human bone morphogenetic protein-2.
    Shaffrey CI; Smith JS
    J Neurosurg Spine; 2013 Feb; 18(2):109-10; discussion 110-1. PubMed ID: 23198758
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.
    Simmonds MC; Brown JV; Heirs MK; Higgins JP; Mannion RJ; Rodgers MA; Stewart LA
    Ann Intern Med; 2013 Jun; 158(12):877-89. PubMed ID: 23778905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
    Burkus JK; Dryer RF; Peloza JH
    J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroma observed 6 months after anterior lumbar interbody fusion that included use of recombinant bone morphogenetic protein 2.
    Scheer JK; Dahdaleh NS; Smith ZA
    Spine J; 2015 Oct; 15(10):e33. PubMed ID: 26022670
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
    Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
    J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Morphogenetic Proteins in Anterior Cervical Fusion: A Systematic Review and Meta-Analysis.
    Zadegan SA; Abedi A; Jazayeri SB; Nasiri Bonaki H; Jazayeri SB; Vaccaro AR; Rahimi-Movaghar V
    World Neurosurg; 2017 Aug; 104():752-787. PubMed ID: 28315798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human bone morphogenetic protein-2-augmented transforaminal lumbar interbody fusion for the treatment of chronic low back pain secondary to the homogeneous diagnosis of discogenic pain syndrome: two-year outcomes.
    Corenman DS; Gillard DM; Dornan GJ; Strauch EL
    Spine (Phila Pa 1976); 2013 Sep; 38(20):E1269-77. PubMed ID: 23778368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion.
    Aichmair A; Girardi FP; Hughes AP; Sama AA; Lebl DR; Cammisa FP
    Spine J; 2013 Oct; 13(10):1411-2. PubMed ID: 24139750
    [No Abstract]   [Full Text] [Related]  

  • 16. A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors.
    Carragee EJ; Ghanayem AJ; Weiner BK; Rothman DJ; Bono CM
    Spine J; 2011 Jun; 11(6):463-8. PubMed ID: 21729794
    [No Abstract]   [Full Text] [Related]  

  • 17. Folly of FDA-approval studies for bone morphogenetic protein.
    Mirza SK
    Spine J; 2011 Jun; 11(6):495-9. PubMed ID: 21729798
    [No Abstract]   [Full Text] [Related]  

  • 18. Medtronic submits full data on spinal protein to independent scrutiny.
    Cohen D
    BMJ; 2011 Aug; 343():d5484. PubMed ID: 21878463
    [No Abstract]   [Full Text] [Related]  

  • 19. Resetting standards for sponsored research: do conflicts influence results?
    Spengler DM
    Spine J; 2011 Jun; 11(6):492-4. PubMed ID: 21729797
    [No Abstract]   [Full Text] [Related]  

  • 20. Exposing conflicts of interest and complications of rhBMP-2.
    Chi JH
    Neurosurgery; 2011 Oct; 69(4):N21-2. PubMed ID: 21900807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.